AASLD/ASGE Endoscopy Course

Endoscopy in the Management of Patients with Liver Disease

Friday, November 7: 7:55 am - 3:00 pm

CME: 7.0 credits
Program Planners

Course Directors:
Marta L. Davila, MD, AGAF, FACG, FASGE and Michael B. Wallace, MD, MPH, FASGE 


Enhance your working knowledge of state-of-the-art practices in the endoscopic management of patients with advanced cirrhosis, biliary tract disease, chronic cholestatic conditions, and other liver diseases—both before and after liver transplantation. The course will cover fundamental issues related to the quality and safety of endoscopic practice in the patient with liver disease, including safe administration of sedation as it relates to disease-specific issues such as coagulopathy. Participants will learn about management and prevention of variceal hemorrhage, as well as advanced endoscopic techniques such as cholangioscopy for biliary disease.

Upon completion of this activity, participants will be able to:

  • Select patients with liver disease who may undergo endoscopic procedures
  • Identify standards of care for treating portal hypertensive conditions, including esophageal and gastric varices and vascular ectasia
  • Choose appropriate testing and staging procedures for patients with biliary strictures and suspected cholangiocarcinoma
  • Recommend appropriate endoscopic procedures for management of biliary complications of transplantation
Meeting App Now Available Via:


 Friday, November 7

3:30 pm - 3:35 pmWelcome and Introduction
 Session I: The ABCs of Inflammation and Immunity in the Liver
3:35 pm - 3:55 pmInflammation and Immunity: A Primer for Hepatologists
3:55 pm - 4:15 pmClinical Consequences of Liver inflammation: An Overview
4:15 pm - 4:35 pmLiver Disease and Immune Cells: The Pathologist's View
4:35 pm - 4:55 pmGut - Liver Axis: Bugs, Probiotics, Bile Acids and Inflammation in Liver Disease
 Session II: Acute Liver Injury: Dead Cells and Surviving Patients
5:10 pm - 5:30 pmSterile Inflammation in Acute Liver Injury: Myth or Mystery?
5:30 pm - 5:50 pmAcute Liver Failure or Multi-Organ Dysfunction Syndrome?
5:50 pm - 6:10 pmABC's of Acute Viral Hepatitis
 Session III: Chronic Hepatitis: Controlling Infection or Causing Inflammation?
6:10 pm - 6:30 pmImmunity and Inflammation in Chronic Hepatitis B in Adults - When to Treat?
6:30 pm - 6:50 pmImmunity and Inflammation in Chronic Hepatitis C - Does Treatment Help?
6:50 pm - 7:20 pmMechanisms and Strategies of Antiviral Therapies in HCV
7:20 pm - 7:30 pmDay 1 Wrap-Up

 Saturday, November 8

 Session IV: Steatohepatitis: ASH and NASH
8:00 am - 8:20 amImmune-Mediated Liver Damage: The Troublemakers and The Peacekeepers
8:20 am - 8:40 amAlcoholic and Non-Alcoholic Steatohepatitis: Similarities and Key Differences in Treatment Options
8:40 am - 9:00 amImmune Activation in the Metabolic Syndrome - Implications for the Clinicians
9:00 am - 9:20 amGrowing Kids and Growing Concerns: Pediatric NAFLD
9:20 am - 9:40 amClinical Management, Current and Emerging Pharmacotherapies in NAFLD and NASH
9:40 am - 10:00 amTrimming the Fat: The Liver and Beyond
 Session V: Autoimmunity and Immune Tolerance in the Liver
10:20 am - 10:40 amClinical Implications of Autoimmunity - Autoimmune Hepatitis and Overlap Syndrome
10:40 am - 11:00 amAutoimmunity in Cholestatic Liver Disease - New Concepts and Therapies
11:00 am - 11:20 amBiliary Atresia: Update on Investigations of Pathogenesis and Outcomes
11:20 am - 11:40 amAutoimmune-Like Drug Induced Liver Injury Case Presentations:
11:40 am - 12:00 pmLiver Transplantation and Allograft Rejection
12:00 pm - 12:20 pmDiscussion
12:20 pm - 1:40 pmLunch
 Session VI: Reversibility of Chronic Liver Disease
1:40 pm - 2:00 pmLiver Fibrosis: The Toll of Inflammation
2:00 pm - 2:20 pmAcute on Chronic Liver Disease: Is There Liver-Gut-Brain Crosstalk?
2:20 pm - 2:50 pmWhat Causes Hepatorenal Syndrome?
2:50 pm - 3:10 pmEmerging Therapies Targeting Inflammation in Liver Disease
 Session VII: From the Past to the Future: Targeted Therapies
3:30 pm - 3:50 pmWhen Immune Surveillance Fails: Managing Hepatocellular Cancer
3:50 pm - 4:10 pmEmerging Trends in Hepatology Practice: Science Driven Care of Liver Diseases and Cancer - From Stem Cells to Genomics
4:10 pm - 4:35 pmIn Search of the Magic Bullet: Can Liver Inflammation and Fibrosis Be Reversed With Medications?
4:35 pm - 5:00 pmEnding Liver Inflammation and Curing Liver Disease: From Test Tubes to Patients

 ‭(Hidden)‬ Custom List View Classes

^ Back to Top